Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-051111
Filing Date
2013-09-30
Accepted
2013-09-30 18:31:43
Documents
1
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd390846.html 3  
1 FORM 3 rrd390846.xml 3 8414
  Complete submission text file 0001181431-13-051111.txt   9823
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Multani Pratik S (Reporting) CIK: 0001586894 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36076 | Film No.: 131124575